Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO)

Affiliation auteurs!!!! Error affiliation !!!!
TitreOutcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO)
Type de publicationJournal Article
Year of Publication2018
AuteursGodet S, Protin C, Dupuis J, Dartigeas C, Bastie J-N, Herbaux C, Leblond V, de Guibert S, Ghez D, Brion A, Ysebaert L, Delmer A, Quinquenel A
JournalAMERICAN JOURNAL OF HEMATOLOGY
Volume93
PaginationE52-E54
Date PublishedFEB
Type of ArticleLetter
ISSN0361-8609
DOI10.1002/ajh.24981